Free Trial

GeneDx (WGS) Earnings Date, Estimates & Call Transcripts

GeneDx logo
$67.78 -4.33 (-6.00%)
Closing price 04:00 PM Eastern
Extended Trading
$69.16 +1.38 (+2.03%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GeneDx Earnings Summary

GeneDx announced Q1 2025 earnings on April 30, 2025, reporting an EPS of $0.28, which beat analysts' consensus estimates of $0.11 by $0.17. Quarterly revenue was reported to be $87.12 million, above the consensus estimate of $79.90 million. With a trailing EPS of -$1.41, GeneDx's earnings are expected to grow 115.46% next year, from $0.97 to $2.09 per share.

Upcoming Q2
Earnings Date
Jul. 29Before Market OpensEstimated
Consensus EPS
(Apr. 30)
$0.11
Actual EPS
(Apr. 30)
$0.28 Beat By $0.17
Actual Revenue
(Apr. 30)
$87.12M

Q1 2025 Earnings Resources

WGS Upcoming Earnings

GeneDx's next earnings date is estimated for Tuesday, July 29, 2025, based on past reporting schedules.

Get GeneDx Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GeneDx and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

WGS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

WGS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

GeneDx Analyst EPS Estimates

Current Year EPS Consensus Estimate
$0.97 EPS
Next Year EPS Consensus Estimate
$2.09 EPS

GeneDx Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/29/2025
(Estimated)
--------
4/30/2025Q1 2025$0.11$0.28+$0.17-$0.23$79.90M$87.12M
2/18/2025Q4 2024$0.04$0.70+$0.66$0.23$82.24M$95.64M
10/29/2024Q3 2024-$0.21$0.04+$0.25$0.39$64.98M$76.90M
7/30/2024Q2 2024-$0.26-$0.11+$0.15$0.88$58.90M$70.51M
4/29/2024Q1 2024-$0.68-$0.33+$0.35$0.12$49.80M$62.42M
2/20/2024Q4 2023-$0.60-$0.59+$0.01-$0.26$57.00M$57.42M
10/30/2023Q3 2023-$1.18-$0.82+$0.36-$53.80M$53.30M
8/8/2023Q2 2023-$1.47-$1.65 -$0.18-$1.46$45.60M$48.71M

GeneDx Earnings - Frequently Asked Questions

GeneDx has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 29th, 2025 based off last year's report dates. Learn more on WGS's earnings history.

GeneDx issued an update on its FY 2025 earnings guidance on Wednesday, April, 30th. The company issued revenue guidance of $360.0 million-$375.0 million, compared to the consensus revenue estimate of $358.6 million.

In the previous quarter, GeneDx (NASDAQ:WGS) reported $0.28 earnings per share (EPS) to beat the analysts' consensus estimate of $0.11 by $0.17. Learn more on analysts' earnings estimate vs. WGS's actual earnings.

The conference call for GeneDx's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for GeneDx's latest earnings report can be read online.
Read Transcript

GeneDx (NASDAQ:WGS) has a recorded annual revenue of $330.14 million.

GeneDx (NASDAQ:WGS) has a recorded net income of -$175.77 million. WGS has generated -$1.41 earnings per share over the last four quarters.

GeneDx's earnings are expected to grow from $0.97 per share to $2.09 per share in the next year, which is a 115.46% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:WGS) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners